Sun.Jun 09, 2024

article thumbnail

Urgent plea for type O blood after London cyberattack

pharmaphorum

NHS launches an urgent appeal for type O blood donors to come forward in the wake of the cyberattack which has hamstrung hospitals and GP services in London

113
113
article thumbnail

Addressing Social Determinants of Health in Clinical Trials and Role of eClinical Systems

Cloudbyz

Social determinants of health (SDOH) encompass non-medical factors that significantly influence health outcomes. These factors include socioeconomic status, education, neighborhood and physical environment, employment, social support networks, and access to healthcare. In the realm of clinical trials, particularly in oncology and rare disease research, SDOH play a pivotal role in shaping patient participation, adherence, and overall outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Less Care at Higher Cost—The Medicare Advantage Paradox

JAMA Internal Medicine

This Viewpoint makes the case for eliminating Medicare Advantage and doubling down on Traditional Medicare.

109
109
article thumbnail

Understanding FDA’s Draft Guidance on Cancer Clinical Trial Eligibility Criteria: Performance Status

Cloudbyz

The FDA’s draft guidance marks a significant step toward more inclusive and relevant cancer clinical trials. Aimed at industry stakeholders, IRBs, and clinical investigators, this document highlights the need to reconsider eligibility criteria to include patients with varying performance statuses (PS). Performance status (PS) is crucial in oncology trials, assessing how patients perform daily activities.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Atherosclerotic CVD Risk Estimates Using the PREVENT Equations

JAMA Internal Medicine

This cross-sectional study compares 10-year atherosclerotic cardiovascular disease risk and recommendations for primary prevention statin therapy between the 2023 American Heart Association (AHA) Predicting Risk of Cardiovascular Disease (CVD) Events (PREVENT) equations and the 2013 AHA/American College of Cardiology pooled cohort equations.

article thumbnail

Solution dosed drug patent expirations by year

Drug Patent Watch

This chart shows the patent expirations for solution dosed drugs over the next decade. The term of drug patents varies.

Drugs 59
article thumbnail

Recurrent Urinary Tract Infection in Older Outpatient Women

JAMA Internal Medicine

This Clinical Insights discusses special considerations in recurrent urinary tract infection diagnosis and management in older women.

82